Milestone Pharmaceuticals (MIST) Return on Equity [ROE] (2018 - 2026)
Milestone Pharmaceuticals (MIST) reported Return on Equity [ROE] of -76.85% for Q3 2022, down 50.91 percentage points from -25.94% a year earlier and down 26.54 percentage points from the prior quarter.
Powered by 
Analysis
Milestone Pharmaceuticals (MIST) Return on Equity [ROE] (2018 - 2026) Analysis & Trends
For FY2021, Milestone Pharmaceuticals posted Return on Equity [ROE] of -33.52%, up 5.21 percentage points from FY2020.
- By year, Return on Equity [ROE] came in at -38.73% in FY2020 (+16.93 pp) and -55.66% in FY2019.
- The Q3 2022 figure ranks as the lowest quarterly Return on Equity [ROE] since Q4 2018.
- Year over year, Return on Equity [ROE] gained in five of the last seven quarters, with an average year-over-year change of +4.60 percentage points.
- The high point for year-over-year Return on Equity [ROE] in five years was Q4 2019 (a gain of 79.79 percentage points); the low point was Q3 2022 (a drop of 50.91 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Milestone Pharmaceuticals | 82.17 Mn | -88.43 Mn | 527,000.00 | -229.93% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -229.93% |
| Mar 31, 2026 | -139.52% |
| Dec 31, 2025 | -177.88% |
| Sep 30, 2025 | -3,662.41% |
| Mar 31, 2025 | -1,271.01% |
| Dec 31, 2024 | -184.92% |
| Sep 30, 2024 | -127.63% |
| Jun 30, 2024 | -115.43% |
| Mar 31, 2024 | -170.43% |
| Dec 31, 2023 | -241.12% |
| Sep 30, 2023 | -162.13% |
| Jun 30, 2023 | -120.88% |
| Mar 31, 2023 | -98.54% |
| Dec 31, 2022 | -81.38% |
| Sep 30, 2022 | -75.81% |
| Jun 30, 2022 | -65.91% |
| Mar 31, 2022 | -41.57% |
| Dec 31, 2021 | -35.71% |
| Sep 30, 2021 | -25.94% |
| Jun 30, 2021 | -23.85% |
API Access
Milestone Pharmaceuticals Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=MIST&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "MIST", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=MIST&period=max&api_key=YOUR_API_KEY");
const data = await res.json();